glp-1 supply expansion news today Glucagon Like Peptide-1 (GLP-1) Agonists Market Report GLP-1 Receptor Agonist Market Valued
Description
What the FDA announced in April 2026 directly affects the legal availability of compounded semaglutide and tirzepatide
Insulin binding to the receptor does not trigger GLUT4 recruitment, as receptor sensitivity is impaired [1,3]
2025;17:e14497
PMID: 37622681
